These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16859528)

  • 41. Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis.
    Andreucci E; Margheri F; Peppicelli S; Bianchini F; Ruzzolini J; Laurenzana A; Fibbi G; Bruni C; Bellando-Randone S; Guiducci S; Romano E; Manetti M; Matucci-Cerinic M; Calorini L
    Rheumatology (Oxford); 2021 Oct; 60(10):4508-4519. PubMed ID: 33471123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12.
    Margheri F; Serratì S; Lapucci A; Chillà A; Bazzichi L; Bombardieri S; Kahaleh B; Calorini L; Bianchini F; Fibbi G; Del Rosso M
    Arthritis Rheum; 2010 Aug; 62(8):2488-98. PubMed ID: 20506099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor.
    Liakouli V; Elies J; El-Sherbiny YM; Scarcia M; Grant G; Abignano G; Derrett-Smith EC; Esteves F; Cipriani P; Emery P; Denton CP; Giacomelli R; Mavria G; Del Galdo F
    Ann Rheum Dis; 2018 Mar; 77(3):431-440. PubMed ID: 29259049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations.
    Nevskaya T; Bykovskaia S; Lyssuk E; Shakhov I; Zaprjagaeva M; Mach E; Ananieva L; Guseva N; Nassonov E
    Clin Exp Rheumatol; 2008; 26(3):421-9. PubMed ID: 18578963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors.
    Tsou PS; Wren JD; Amin MA; Schiopu E; Fox DA; Khanna D; Sawalha AH
    Arthritis Rheumatol; 2016 Dec; 68(12):2975-2985. PubMed ID: 27482699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.
    Mazzotta C; Manetti M; Rosa I; Romano E; Blagojevic J; Bellando-Randone S; Bruni C; Lepri G; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Res Ther; 2017 Feb; 19(1):27. PubMed ID: 28183357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiogenesis and vasculogenesis in systemic sclerosis.
    Distler JH; Gay S; Distler O
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii26-7. PubMed ID: 16987827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity.
    Michalska-Jakubus M; Cutolo M; Smith V; Krasowska D
    Microvasc Res; 2019 Sep; 125():103881. PubMed ID: 31075243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Vascular changes in the pathogenesis of systemic sclerosis].
    Distler JH; Kalden JR; Gray S; Distler O
    Z Rheumatol; 2004 Dec; 63(6):446-50. PubMed ID: 15605207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.
    Mostmans Y; Cutolo M; Giddelo C; Decuman S; Melsens K; Declercq H; Vandecasteele E; De Keyser F; Distler O; Gutermuth J; Smith V
    Autoimmun Rev; 2017 Aug; 16(8):774-786. PubMed ID: 28572048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contribution to the peripheral vasculopathy and endothelial cell dysfunction by CXCL4 in Systemic Sclerosis.
    Jiang Z; Chen C; Yang S; He H; Zhu X; Liang M
    J Dermatol Sci; 2021 Oct; 104(1):63-73. PubMed ID: 34556381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis.
    Noda S; Asano Y; Aozasa N; Akamata K; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Arch Dermatol Res; 2013 May; 305(4):325-31. PubMed ID: 23233281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma-like Vasculopathy in KLF5
    Nakamura K; Taniguchi T; Hirabayashi M; Yamashita T; Saigusa R; Miura S; Takahashi T; Toyama T; Ichimura Y; Yoshizaki A; Trojanowska M; Fujiu K; Nagai R; Sato S; Asano Y
    Arthritis Rheumatol; 2020 Dec; 72(12):2136-2146. PubMed ID: 32627966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genome-Wide Reduction in Chromatin Accessibility and Unique Transcription Factor Footprints in Endothelial Cells and Fibroblasts in Scleroderma Skin.
    Tsou PS; Palisoc PJ; Ali M; Khanna D; Sawalha AH
    Arthritis Rheumatol; 2021 Aug; 73(8):1501-1513. PubMed ID: 33586346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of angiogenesis by platelets in systemic sclerosis patients.
    Hirigoyen D; Burgos PI; Mezzano V; Duran J; Barrientos M; Saez CG; Panes O; Mezzano D; Iruretagoyena M
    Arthritis Res Ther; 2015 Nov; 17():332. PubMed ID: 26584613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic down-regulation of microRNA-126 in scleroderma endothelial cells is associated with impaired responses to VEGF and defective angiogenesis.
    Wang Y; Sun J; Kahaleh B
    J Cell Mol Med; 2021 Jul; 25(14):7078-7088. PubMed ID: 34137496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone marrow endothelial progenitors are defective in systemic sclerosis.
    Del Papa N; Quirici N; Soligo D; Scavullo C; Cortiana M; Borsotti C; Maglione W; Comina DP; Vitali C; Fraticelli P; Gabrielli A; Cortelezzi A; Lambertenghi-Deliliers G
    Arthritis Rheum; 2006 Aug; 54(8):2605-15. PubMed ID: 16868984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Global gene expression analysis of systemic sclerosis myofibroblasts demonstrates a marked increase in the expression of multiple NBPF genes.
    Abignano G; Hermes H; Piera-Velazquez S; Addya S; Del Galdo F; Jimenez SA
    Sci Rep; 2021 Oct; 11(1):20435. PubMed ID: 34650102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers.
    Gunningham SP; Currie MJ; Morrin HR; Tan EY; Turley H; Dachs GU; Watson AI; Frampton C; Robinson BA; Fox SB
    J Pathol; 2007 Jul; 212(3):335-44. PubMed ID: 17487938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice.
    Margheri F; Serratì S; Lapucci A; Anastasia C; Giusti B; Pucci M; Torre E; Bianchini F; Calorini L; Albini A; Ventura A; Fibbi G; Del Rosso M
    Neoplasia; 2009 Oct; 11(10):1106-15. PubMed ID: 19794969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.